The mucosal vaccine quandary: intranasal vs. sublingual immunization against influenza. (Q38001862)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22495121%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

The mucosal vaccine quandary: intranasal vs. sublingual immunization against influenza (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22495121%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22495121%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Gabriel Pedersen

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22495121%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

1 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22495121%20AND%20SRC:MED&resulttype=core&format=json

Human Vaccines & Immunotherapeutics

28 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22495121%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22495121%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22495121%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

689-693

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22495121%20AND%20SRC:MED&resulttype=core&format=json

Mucosal vaccines: the promise and the challenge

28 January 2020

cites work

1 reference

The global burden of disease attributable to contaminated injections given in health care settings

21 January 2018

1 reference

Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.

21 January 2018

1 reference

Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine

21 January 2018

1 reference

Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults.

21 January 2018

1 reference

An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults

21 January 2018

1 reference

Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit

21 January 2018

1 reference

Intranasal vaccination with ISCOMATRIX adjuvanted influenza vaccine.

21 January 2018

1 reference

Matrix-M adjuvanted virosomal H5N1 vaccine confers protection against lethal viral challenge in a murine model

21 January 2018

1 reference

CAF01 liposomes as a mucosal vaccine adjuvant: In vitro and in vivo investigations

21 January 2018

1 reference

A single intranasal immunization with inactivated influenza virus and alpha-galactosylceramide induces long-term protective immunity without redirecting antigen to the central nervous system

21 January 2018

1 reference

Type I IFN as a vaccine adjuvant for both systemic and mucosal vaccination against influenza virus

21 January 2018

1 reference

Intranasal c-di-GMP-adjuvanted plant-derived H5 influenza vaccine induces multifunctional Th1 CD4+ cells and strong mucosal and systemic antibody responses in mice

21 January 2018

1 reference

Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans

21 January 2018

1 reference

Effects of different adjuvants in the context of intramuscular and intranasal routes on humoral and cellular immune responses induced by detergent-split A/H3N2 influenza vaccines in mice

21 January 2018

1 reference

Needle-free influenza vaccination.

21 January 2018

1 reference

Mucosal adjuvants and long-term memory development with special focus on CTA1-DD and other ADP-ribosylating toxins

21 January 2018

1 reference

NALT- versus Peyer's-patch-mediated mucosal immunity

21 January 2018

1 reference

Evaluation of the sublingual route for administration of influenza H5N1 virosomes in combination with the bacterial second messenger c-di-GMP

21 January 2018

1 reference

Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection

21 January 2018

1 reference

Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza

21 January 2018

1 reference

STING is a direct innate immune sensor of cyclic di-GMP

21 January 2018

1 reference

Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88

21 January 2018

1 reference

Mutants of the Escherichia coli heat-labile enterotoxin as safe and strong adjuvants for intranasal delivery of vaccines

21 January 2018

1 reference

Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin

21 January 2018

1 reference

Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations

21 January 2018

1 reference

Evidence of connections between cerebrospinal fluid and nasal lymphatic vessels in humans, non-human primates and other mammalian species

21 January 2018

1 reference

Is nose-to-brain transport of drugs in man a reality?

21 January 2018

1 reference

Delivery of interferon-beta to the monkey nervous system following intranasal administration

21 January 2018

1 reference

Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system

21 January 2018

1 reference

Temperature-sensitive parainfluenza type 1 vaccine virus directly accesses the central nervous system by infecting olfactory neurons

21 January 2018

1 reference

Sublingual vaccination with influenza virus protects mice against lethal viral infection

21 January 2018

1 reference

Subclinical brain injury caused by H5N1 influenza virus infection

21 January 2018

1 reference

Productive infection in the murine central nervous system with avian influenza virus A (H5N1) after intranasal inoculation

21 January 2018

1 reference

The invasion routes of neurovirulent A/Hong Kong/483/97 (H5N1) influenza virus into the central nervous system after respiratory infection in mice

21 January 2018

1 reference

Pathogenesis of Influenza A/H5N1 virus infection in ferrets differs between intranasal and intratracheal routes of inoculation

21 January 2018

1 reference

Editorial: Nitrates in the prophylactic treatment of angina pectoris

21 January 2018

1 reference

Immune mechanisms of allergen-specific sublingual immunotherapy

21 January 2018

1 reference

Systemic immune responses induced by mucosal administration of lipopeptides without adjuvant

21 January 2018

1 reference

21 January 2018

Mucosal dendritic cells

1 reference

CCR7-CCL19/CCL21-regulated dendritic cells are responsible for effectiveness of sublingual vaccination

21 January 2018

1 reference

Neonatal sublingual vaccination with Salmonella proteins and adjuvant cholera toxin or CpG oligodeoxynucleotides induces mucosal and systemic immunity in mice

21 January 2018

1 reference

Sublingual immunization protects against Helicobacter pylori infection and induces T and B cell responses in the stomach

21 January 2018

1 reference

Sublingual therapeutic immunization with a polyvalent bacterial preparation in patients with recurrent respiratory infections: immunomodulatory effect on antigen-specific memory CD4+ T cells and impact on clinical outcome.

21 January 2018

1 reference

Enhanced humoral and cellular immune responses after sublingual immunization against human papillomavirus 16 L1 protein with adjuvants

21 January 2018

1 reference

Sublingual immunization with nonreplicating antigens induces antibody-forming cells and cytotoxic T cells in the female genital tract mucosa and protects against genital papillomavirus infection.

21 January 2018

1 reference

21 January 2018

Sublingual vaccination

1 reference

21 January 2018

Identifiers

DOI

10.4161/HV.19568

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22495121%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference